Avalon GloboCare Corp. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ALBT Nasdaq 3840 www.avalon-globocare.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avalon GloboCare Corp.

Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement - Apr 29th, 2025 12:00 pm
Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir - Apr 15th, 2025 12:00 pm
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China - Apr 10th, 2025 12:00 pm
Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series - Apr 1st, 2025 1:00 pm
Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement - Mar 10th, 2025 12:00 pm
Fusion Fuel Appoints Luisa Ingargiola to Board of Directors - Feb 27th, 2025 1:00 pm
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China - Feb 18th, 2025 2:00 pm
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements - Nov 21st, 2024 2:00 pm
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Nov 15th, 2024 12:31 pm
Top Premarket Decliners - Nov 4th, 2024 12:55 pm
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - Oct 31st, 2024 1:00 pm
Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving - Oct 25th, 2024 1:00 pm
EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer - Oct 25th, 2024 12:31 pm
Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan - Oct 24th, 2024 1:00 pm
Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device - Oct 9th, 2024 1:00 pm
Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device - Aug 14th, 2024 12:00 pm
EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device - Aug 14th, 2024 11:30 am
Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction - Jul 31st, 2024 12:00 pm
7 F-Rated Penny Stocks to Avoid This June - Jun 21st, 2024 11:30 am
Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference - Jun 20th, 2024 12:30 pm